CKD Bio said it has confirmed the non-inferiority of CKDB-501A, aimed at improving moderate to severe frown lines, compared to Botox through a phase 3 clinical trial's topline results.The analysis of the data revealed that the improvement rate for frown lines when frowning was 80.69 percent (117 out
The government fully allowed contactless medical treatment starting Friday in response to the medical community's collective action in protest against increasing the medical school enrollment quota.The permission will continue until the end of the doctors' strike. Telemedicine will be allowed at all
A new proposal for the expansion of medical school quotas by Professor Shin Young-seok of the Korea University Graduate School of Public Health, the principal researcher who previously provided the basis for the government's plan to increase the number of medical students by 2,000, is drawing signif
LG Chem said Friday that the company opened an aesthetic “Solution Lab Center" in Caiting Hospital, which specializes in cosmetic surgery in Shanghai, to expand expand its educational support for YVOIRE (LG Chem's hyaluronic acid filler’s brand name) customers in China.LG Chem’s Executive Vice Presi
GC Cell said that its U.S. affiliate, Artiva Biotherapeutics, has received fast-track designation from the U.S. FDA for their investigational lupus nephritis treatment, AlloNK (development code name: AB-101).The fast track designation is intended to facilitate the development and expedite the review
AbbVie's oral migraine prophylaxis Aquipta (atogepant) met its primary endpoint in a phase 3 clinical trial of patients who failed prior oral prophylaxis, reducing the average number of migraine days per month.AbbVie Korea said Friday that the full results of the phase 3 ELEVATE study were published
A typhoid conjugate vaccine developed by SK bioscience has received the World Health Organization's (WHO) Pre-Qualification (PQ) certification, a green light to enter new overseas markets.SK bioscience said Friday that its typhoid conjugate vaccine, SKYTyphoid Multi-Injection (NBP618 in the project
Janssen has been delaying the Korean launch of its FGFR (fibroblast growth factor receptor) inhibitor Balversa (erdafitinib) for over a year, making many watchers wonder what's happening.Janssen received approval for Balversa on Nov. 24, 2022, from the Ministry of Food and Drug Safety (MFDS).Balvers
At a government-business meeting early this week, the Ministry of Food and Drug Safety (MFDS) announced its intention to support exporting Korean medical products based on regulatory harmonization. Welcoming the move, pharmaceutical companies made several requests to open the way for exporting their
The Korea Research-based Pharmaceutical Industry Association (KRPIA) announced that it has appointed Bae Kyung-eun, General Manager of Sanofi-Aventis Korea, as the 15th chairperson of the association.This decision was made during the association's board meeting, marking a new chapter in KRPIA's lead
Genuv, an innovative drug discovery venture, has been selected to receive funding from the Alzheimer's Drug Discovery Foundation (ADDF) in the United States.The ADDF, supported by the Estée Lauder family and the Bill & Melinda Gates Foundation, selects Alzheimer's projects worldwide based on their t
To combat acquired immunodeficiency syndrome (AIDS), the government will focus on preventing new infections of the human immunodeficiency virus (HIV) and drastically improving access to healthcare.As a means of expanding medical access, it will actively detect patients, expand opportunities for self
Alteogen, a Kosdaq-listed biotech company, said it has made an amendment to its existing license agreement with the global pharmaceutical company MSD, known as Merck & Co. in the U.S. and Canada.The revised agreement grants MSD exclusive global rights to ALT-B4, a recombinant human hyaluronidase enz
The oriental medicine community has called for putting traditional medicine practitioners into the medical field to fill the healthcare vacuum caused by striking doctors. On Thursday, however, the Ministry of Health and Welfare drew a line on the issue, saying, “We can’t do that.”In response to the
Samsung Bioepis said it has made significant progress with its autoimmune disease treatment biosimilar, SB17, suggesting its potential use across all indications treatable by the original drug, Stelara.Stelara is an interleukin (IL)-12, 23 inhibitor developed by Janssen. It is used to treat inflamma
Proponents of the medical school enrollment quota increase have maintained that Korea needs to lower doctors’ income to an optimal level by expanding the number of physicians and avoiding falling into a “medical school black hole.”The "medical school black hole" in Korea refers to a phenomenon where
Myongji Hospital has begun performing TAVI (transcatheter aortic valve implantation), one of the most difficult cardiovascular procedures.The hospital was certified as a TAVI provider by the Ministry of Health and Welfare last year and has since been performing TAVI procedures in earnest, with Profe
Nine-thousand-two-hundred-and-seventy-five trainee doctors have resigned at 100 major training hospitals nationwide, the Ministry of Health and Welfare said Thursday. Those who left their workplaces numbered 8,024.The ministry announced the result of its field checks on doctors’ collective action at
In a move to combat the rising threat of cardiovascular disease (CVD) in the Asia-Pacific region, Korea Biomedical Review (KBR) has announced its partnership with the APAC CVD Alliance on Thursday. Yang Kyung-cheol, CEO and publisher of KBR, and Dr. Krishna Reddy Nallamalla, CEO of ACCESS Health Int
Dongkook Pharmaceutical said it signed a memorandum of understanding with Oncovix to commercialize functional materials at its headquarters office in Cheongdam-dong, southern Seoul, last Friday.Through this agreement, the two companies will jointly develop new drugs with antibacterial and anti-infla